Clinical Trial Update: Prompt Panretinal Photocoagulation Versus Ranibizumab+Deferred Panretinal Photocoagulation for Proliferative Diabetic Retinopathy [Phase 3]

View source ↗

Summary

Phase 3 trial comparing prompt panretinal photocoagulation to ranibizumab with deferred laser for proliferative diabetic retinopathy has completed with results …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Proliferative Diabetic Retinopathy

Drugs mentioned

• Ranibizumab (ranibizumab)

Snippet

Sponsor: Jaeb Center for Health Research | Conditions: Proliferative Diabetic Retinopathy | Phase 3 | Status: COMPLETED | Results posted: 2016-06-01